Dees, E. Claire
University of North Carolina at Chapel Hill · UNC Lineberger Comprehensive Cancer Center
6 papers on CoChatORCID 0000-0003-4004-7316
Most cited papers
- Verified
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., et al. (2018) · New England Journal of Medicine
Breast Cancer Treatment StudiesBRCA gene mutations in cancer
Cited by 2,397
- Verified
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Nanda, R., Chow, L. Q. M., Dees, E. C., Berger, R., Gupta, S., Geva, R., Pusztai, L., Pathiraja, K., Aktan, G., Cheng, J. D., et al. (2016) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 1,477
- Verified
A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer
Dees, E. C., O'reilly, S., Goodman, S. N., Sartorius, S., Levine, M. A., Jones, R. J., Grochow, L. B., Donehower, R. C., & Fetting, J. H. (2000) · Cancer Investigation
Breast Cancer Treatment StudiesCancer Treatment and Pharmacology
Cited by 180
- Verified
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
Soliman, H. H., Jackson, E., Neuger, T., Dees, E. C., Harvey, R. D., Han, H., Ismail-Khan, R., Minton, S., Vahanian, N. N., Link, C., et al. (2014) · Oncotarget
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 174
- Verified
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
Mitin, N., Nyrop, K. A., Strum, S. L., Knecht, A., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., et al. (2022) · npj Breast Cancer
Cancer Treatment and PharmacologyChemotherapy-related skin toxicity
Cited by 17
- Verified
a phase 1, first in human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors
Bauml, J., Barton, D., Ronczka, A., Cushing, D., Klichinsky, M., & Dees, E. C. (2021) · Cytotherapy
CAR-T cell therapy researchVirus-based gene therapy research
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free